SCHEMBL21164487

SCHEMBL21164487

CCCC(C)(C)C(=O)Nc1nc(C(C)(C)C)cs1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATAD2 Q6PL18 1/20 0.53
KMT2A Q03164 7/20 0.52
NPC1 O15118 7/20 0.52
RAB9A P51151 7/20 0.52
MEN1 O00255 5/20 0.52
ALDH1A1 P00352 4/20 0.52
SMN1; SMN2 Q16637 3/20 0.52
MAPK1 P28482 3/20 0.52
POLB P06746 2/20 0.52
TAS1R3 Q7RTX0 1/20 0.52
TAS1R1 Q7RTX1 1/20 0.52
TAS1R2 Q8TE23 1/20 0.52
HPGD P15428 2/20 0.52
LMNA P02545 5/20 0.51
NPSR1 Q6W5P4 3/20 0.51
HSD17B10 Q99714 2/20 0.51
ALOX15 P16050 1/20 0.51
TSHR P16473 1/20 0.51
MAPT P10636 2/20 0.51
RECQL P46063 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21791799 0.88 ATAD2 (0.56) ATAD2KMT2ANPC1RAB9AMEN1
SCHEMBL77451 0.82 ATAD2 (0.61) ATAD2KMT2ANPC1RAB9AMEN1
SCHEMBL77089 0.79 KMT2A (0.67) ATAD2KMT2ANPC1RAB9AMEN1
SCHEMBL77628 0.79 ALDH1A1 (0.64) ATAD2KMT2ANPC1RAB9AMEN1
SCHEMBL1621015 0.79 ATAD2 (0.49) ATAD2KMT2ANPC1RAB9AMEN1
SCHEMBL20788543 0.78 NPC1 (0.77) ATAD2KMT2ANPC1RAB9AMEN1
SCHEMBL77627 0.77 NPC1 (0.59) ATAD2KMT2ANPC1RAB9AMEN1
SCHEMBL3790984 0.77 NPC1 (0.66) ATAD2KMT2ANPC1RAB9AMEN1
SCHEMBL2608447 0.77 ATAD2 (0.63) ATAD2KMT2ANPC1RAB9AMEN1
SCHEMBL1621496 0.77 NPC1 (0.47) ATAD2KMT2ANPC1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10351883-B2 Compounds for increasing lipid synthesis and storage NUTECH VENTURES (US) 2019-07-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10351883-B2 Compounds for increasing lipid synthesis and storage FASN, LIPC, SREBF2 ATAD2 2735/4885KMT2A 2512/4885NPC1 70/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.